TCR2 Therapeutics to Present at the 2018 Keystone Symposia Conference on Emerging Cellular Therapies: T Cells and Beyond

February 5, 2018

Responsive image

CAMBRIDGE, Mass., Feb. 5, 2018 /PRNewswire/ — TCR2 Therapeutics Inc. announced today that its Chief Scientific Officer, Robert Hofmeister, Ph.D., has been invited to present at the prestigious Keystone Symposia Conference on Emerging Cellular Therapies: T Cells and Beyond being held…

Category: Precious Metals